Many investors appear to be quite bearish on Dendreon Corporation (DNDN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 26.92% of the float is ...

Dendreon Corporation (DNDN) soars after the biotechnology company reported fourth-quarter earnings that surpassed analysts’ expectations. Dendreon reported a loss of 17 cents per share, which beat the ...

Investors are always looking for stocks that are poised to beat at earnings season and Dendreon Corp. (DNDN) may be one such company. The firm has earnings coming up pretty soon, and events are ...

In trading on Thursday, shares of Dendreon Corp (NASD: DNDN) crossed below their 200 day moving average of $5.48, changing hands as low as $5.46 per share. Dendreon Corp shares are currently trading ...

“We believe that the fourth quarter may be our strongest quarter of the year,” said John Johnson, Dendreon Corporation (NASDAQ:DNDN)‘s chairman, CEO, and president. Where have we heard the ...

Dendreon Corporation (NASDAQ:DNDN) was in 13 hedge funds’ portfolio at the end of March. DNDN has seen a decrease in support from the world’s most elite money managers recently. There were 13 hedge ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Cramer in a question from a student tonight on CNBC’s MAD ...

The reimbursement decision is a big deal because most prostate cancer patients are over 65, and hence covered by Medicare, and allowing off-label use could really open up the market for the ...